INTRODUCTION
Cultured human umbilical vein endothelial cells produce prostacyclin (prostaglandin I2), a potent vasodilator and inhibitor of platelet aggregation, from arachidonic acid (1, 2) . In mammals arachidonic acid is synthesized from linoleic acid, the most abundant polyunsaturated fatty acid usually present in the diet. A number of cultured cells, including human diploid fibroblasts, are able to convert linoleic to arachidonic acid (3) (4) (5) . Those cultures that cannot perform this conversion are for the most part transformed rodent cell lines (3, 4) , and it has been suggested that the deletion of this capacity is somehow associated with malignant transformation (3) . Based upon this, one might expect that the endothelial cells, which are primary diploid cultures, would be able to convert linoleic to arachidonic acid so as to insure a readily available supply of substrate for prostacyclin production.
When cultured human umbilical vein endothelial cells are enriched with linoleic acid, however, their ability to produce prostacyclin in response to stimulation with thrombin or a calcium ionophore is reduced (6) . Likewise, their capacity to inhibit platelet aggregation is decreased, presumably because of the lesser prostacyclin release (7) . One factor that appears to regulate prostaglandin production by cultured cells is the amount of arachidonic acid contained in cellular lipids (8) . Therefore, we have examined the factors that influence the arachidonic acid content of the endothelial cultures in an attempt to explain the apparently anomalous findings noted above (6, 7) . In particular, we investigated the capacity of the endothelial cells to convert linoleic to arachidonic acid, their ability to use extracellular arachidonic acid, and the extent to which different types of fatty acid can interfere with arachidonic acid incorporation into cellular phospholipids.
METHODS
Endothelial cell cultures. Endothelial cells were obtained from human umbilical veins (9) , and primary cultures were prepared according to a slight modification of the method of Jaffe et al. (10) as described (6) . Briefly, the cells were suspended in a modified medium 199 containing 20% heatinactivated fetal bovine serum, counted with a hemocytometer, and seeded in 25-Cm2 flasks at a concentration of 2.25 x 106 cells per flask. After incubation for 24 h at 37°C in an atmosphere of 5% CO2, this medium was replaced with 3 ml ofmedium 199 containing 25 mM Hepes plus 20% fetal bovine serum, and the cultures were continued in the 5% CO2 atmosphere.
Preparation of fatty acid-supplemented media. Fatty acids were purchased from NuCheck Prep (Elysian, Minn.) and were >99% pure as determined by gas-liquid chromatography. [1-_4C] Stearic acid, [1-14C] linoleic acid, [1-'4C] eicosatrienoic acid (n-6 class), [1-14C] arachidonic acid, and [5, 6, 8, 9, 11, 12, 14, 15 -3H]arachidonic acid (hereafter called [3H]arachidonic acid) were obtained from New England Nuclear (Boston, Mass.). These isotopes were checked for purity by thin-layer and gas-liquid chromatography. Where purities were <95%, the isotopes were repurified by a combination of preparative thin-layer and gas-liquid chtomatography. Fetal bovine serum was supplemented with fatty acid by adding a warm solution ofthe sodium salt with mechanical stirring. Before supplementation, the serum contained 0.29
A.mol/ml of free fatty acid with a 17-nmol/ml concentration of free linoleic acid and a 29-nmol/ml concentration of arachidonic acid. Free fatty acid concentration was measured colorimetrically (11) , and individual fatty acids were determined by gas-liquid chromatography (6) . Experimental media were prepared by adding the fatty acid-supplemented fetal bovine serum to medium 199 containing 25 mM Hepes. The medium was adjusted to pH 7.4 at 37°C and sterilized by filtration through a 0.22 micron filter.
Incubation and analyses. The maintenance medium was removed, and the endothelial cell monolayers were washed twice with 2.5 ml of a buffer solution containing 137 mM NaCl, 5 mM KC1, 8 mM Na2HPO4, anid 2 mM KH2PO4, pH 7.4. After addition of 2.5 ml of the fatty acid-supplemented medium, the incubations were carried out at 37°C with a 5% CO2 atmosphere. The incubations were terminated by aspirating the medium, followed by washing the monolayer twice with 2 ml of ice-cold buffer solution. After harvesting by scraping, the cells were suspended in the cold buffer, sedimented at 600 g for 10 min at 4°C, and suspended in 1 ml of fresh cold buffer. A portion of the suspension was removed for determination of the cell protein content (12) . The remainder ofthe suspension was extracted with 20 vol ofa mixture of chloroform and methanol (2:1, vol/vol) in order to isolate the cell lipid content (13) . Following separation and isolation of the chloroform phase, the solvent was evaporated under N2, and the lipid residue was dissolved in a measured volume of fresh chloroform.
In an attempt to validate this method for terminating the incubations and isolating the cells, especially with regard to studies involving radioactive arachidonic acid, we carried out an experiment in which the cells were incubated with a mixture of [3H]arachidonic acid and [1-14C]stearic acid. One set of incubations was terminated by the scraping procedure described above whereas in the other, the incubations were terminated by addition of trichloroacetic acid. Lipids were extracted from each set of cultures, and the ratio of "4C/3H in the cell phospholipids was measured. When the scraping procedure was used, the value obtained was 0.192±0.002. A value of 0.195+0.005 was obtained using the trichloroacetic acid procedure. These results indicate that the cell isolation procedure involving scraping did not lead to an excessive loss of arachidonic acid from the cell phospholipids. It was concluded that this procedure was valid within the limits of currently available methodology.
Separation of phospholipids and neutral lipids was obtained by thin-layer chromatography on silica gel G with a solvent system containing hexane-diethyl ether acetic acidmethanol (170:40:4:4). Standards obtained from NuCheck Prep were added to each chromatogram, and the lipids were visualized by exposure to 12 vapor. After sublimation, the outlined segments of silica gel were scraped into liquid scintillation counting vials. Phospholipids were separated by thin-layer chromatography on silica gel H using a modification of the method of Skipski et al. (14) . This modification, which separates the inositol and serine phosphoglycerides, uses a solvent system containing chloroformmethanol-acetic acid-water (100:50:16:8). The Rfvalues for the major phospholipid classes in these chromatograms are: lysophosphatidylcholine, 0.08; sphingomyelin, 0.22; phosphatidylcholine, 0.40; phosphatidylinositol, 0.65; phosphatidylserine, 0.72; phosphatidylethanolamine, 0.90.
The phospholipid content of the cell lipid extract or of the individual fractions separated by thin-layer chromatography was measured colorimetrically with the malachite green reagent (15) . A micromodification of the fluorometric method that utilizes sodium periodate and acetylacetone was used to measure the triglyceride content (16) .
Fatty acids were isolated from the various lipid classes by saponification, acidification, and extraction into hexane (17) . After methylation with 14% BF3 in methanol (18) , the fatty acid methyl esters were extracted into hexane and separated by gas-liquid chromatography (17) . Separation was achieved using a 2 mm x 1.9-m glass column packed with 10% SP2330 on 100/120 mesh Chromosorb W-AW (Supelco, Inc., Bellefonte, Pa.). The Hewlett-Packard model 5700 gas chromatograph (Hewlett-Packard Co., Palo Alto, Calif.) was equipped with a 9:1 stream splitter so that a portion of the effluent could be collected when radiolabeled material was chromatographed. A flame ionization detector was used. N2 served as the carrier gas at a flow rate of 25 ml/min, and the oven temperature was programmed from 176°to 220°C. Peak areas were determined with a Hewlett-Packard model 3380S integrator-recorder, and areas are reported as weight percentages. In several experiments radioactivity present in the effluent stream was diverted by the stream splitter through a heated collecting port and trapped in a 5-cm length of Teflon tubing immersed in liquid scintillation solution (19) . Preliminary studies with this collection system revealed that >96% of previously purified [1-14C] linoleic acid was recovered in the linoleic acid peak even when this acid comprised <20% of a fatty acid mixture.
Radioactivity was measured in a liquid scintillation spectrometer using counting vials containing 10 ml of Budget Solve scintillator solution (Research Products International, Elk Grove Village, Ill.). Quenching was monitored with a 226Ra extemal standard.
RESULTS
Supplementation with linoleic acid. To follow the time-dependent changes in cellular fatty acid composition, the endothelial cell cultures were exposed to 150 ,mol/liter supplemental linoleic acid during a 72-h culture period. The changes in fatty acyl composition of the cellular phospholipid and neutral lipid fractions during this time of culture are shown in Fig. 1 . Most of the changes that occurred in both fractions took place during the first 24 h. In the cell phospholipids (upper panel), linoleic acid (18:2)1 increased from 6 to 22% of the fatty acyl groups during the 72-h period. This increase was compensated for primarily by a reduction in the oleic acid (18:1) content of the phospholipids from 25 to 15%. Docosadienoic acid (20:2), the direct elongation product of 18:2, increased from 0.4 to 2.5% as the phospholipids became enriched with 18:2. On the other hand, arachidonic acid (20:4) decreased from 13.4 to 8.7% of the phospholipid fatty acyl groups as this fraction became enriched with 18:2. The cellular phospholipid content did not change appreciably during the 72-h period: 557±+12 ,ug/mg cell protein initially and 538+20 at the end of the supplementation period. Therefore, the percentage changes shown in Fig. 1 represent differences in the fatty acid composition of the usual complement of cellular phospholipids, rather than an accumulation of excess phospholipid in the cells.
Cell neutral lipids also became enriched with 18:2, the increase being from 6 to 35% over the 72-h period. This was accompanied by an increase in 20:2 from 0.1 to 3.7%. However, there was very little change in 20:4, this varying from 2.9 to 3.9%. Stearic acid (18:0) was the only other neutral lipid fatty acid to change appreciably, this decreasing from 23 to 9%. As opposed to the cellular phospholipids, however, the quantity of triglycerides incieased from 14+3 to 71 ± 11 ,ug/mg cell protein during the supplementation period. Therefore, the changes in neutral lipid fatty acyl composition were associated with considerable triglyceride accumulation in the cells.
Utilization Table I shows the distribution ofthe incorporated radioactivity among the major polyunsaturated fatty acids of the linoleic acid series. In both the phospholipid and neutral lipid fractions, most of the radioactivity remained as 18:2, even after 72 h of incubation. Only trace quantities of radioactivity were present in 18:3. Very little of the incorporated radioactivity was converted to either 20:3 or 20:4, the maximum amount being 2.0 and 2.9%, respectively, in the phospholipids after 72 h. There was a brisk elongation of 18:2 to 20:2, however, and 20:2 contained about 10% of the radioactivity contained in both fractions after 72 h. These isotopic fiindings are consistent with the fatty acid composition data presented in Fig. 1 [1-14C] arachidonic acid into the cell triglycerides and phospholipids during a 4-h incubation with a medium containing 20% fetal bovine serum and 150 ,umol/liter arachidonic acid was roughly linear, with the triglycerides containing about twice as much radioactivity. The diglyceride fraction, which contained only about 1-5% of the radioactivity, reached a steadystate level within the first hour of incubation. The free fatty acid fraction, which also reached a steady state level during the first hour, contained about 5% of the radioactivity. There was also a progressive increase in the radioactivity contained in each of the individual phospholipid fractions over the 4-h incubation.
To determine the extent to which these results were representative, we examined the effect of lower arachidonic acid concentrations that are more in the range of those occurring in the plasma free fatty acid fraction. The concentrations tested were 5-52 gmol/liter, and the time of incubation was 4 h. As seen in the upper part of Fig. 2 , incorporation of arachidonate radioactivity into each of the major cell lipid classes increased as the extracellular concentration was raised, but the concentration dependence varied among the different fractions. Incorporation into triglycerides showed the greatest concentration dependence, the increase being 4.2-fold. At the lowest arachidonic acid concentration tested, 5 umol/liter, 33% more radioactivity was recovered in cell phospholipids as compared with triglycerides. By contrast, more radioactivity was recovered in triglycerides than phospholipids at each of the higher arachidonate concentrations. Only small amounts of radioactivity were incorporated into the cell diglyceride and free fatty acid fractions at all of the concentrations tested. The distribution of radioactivity in the individual phospholipid fractions is shown in the lower part of Fig. 2 . Increasing amounts ofradioactivity were recovered in the choline and ethanolamine phosphoglycerides as the arachidonic acid concentration was raised, with the choline fraction exhibiting the most marked concentration dependence. Little concentration dependence was noted for the inositol phosphoglycerides, and the incorporation into the serine fraction actually appeared to decrease as the arachidonic acid concentration was raised. Except at the lowest concentration tested, the incorporation of radioactivity into the choline phosphoglycerides was considerably greater than into any of the other phospholipid fractions.
Competition between fatty acids. Studies were done to determine the extent to which other long-chain fatty acids compete with arachidonic acid for incorporation into cellular phospholipids. In these experiments, the [3H]arachidonic acid concentration was held constant at 10 ,umol/liter, whereas the concentration of the second fatty acid was raised to as much as 180 ,umol/liter. (21) . Therefore, it is unlikely that the conversion of linoleic to arachidonic acid is limited by the elongation step. Each of the two desaturations in the pathway is mediated by a separate microsomal enzyme (22) . A fatty acid A6-desaturase converts 18:2 to 18:3, whereas the conversion of 20:3 to 20:4 is mediated by a AS-desaturase. Because the endothelial cells converted radioactive 20:3 to 20:4, the A5-desaturase is operative. This leads to the conclusion that the inactive step in the pathway is the A6-desaturase reaction. Some A9-desaturase activity, which converts 18:0 to 18:1 also was present in these cells. These findings indicate that the cells do not have a generalized desaturase deficiency. Like the endothelial cultures, several other cell lines are reported to have a A6-desaturase deficiency. These include the L-fibroblast (3) , LM cell (3, 4, 23) , HSDM fibrosarcoma (3), and Chang liver cell (4). However, a number of other cultured cells contain this activity, including mouse neuroblastoma (24), human skin fibroblasts (3, 5) , and human lung fibroblasts (3, 4) . Therefore, the A6-desaturase deficiency appears to be unrelated to the fact that the endothelial cells were cultured.
Competition between linoleic and arachidonic acids for incorporation into phospholipids, the second factor that contributes to the reduction in arachidonic acid content, could occur at the level of either the acyl coenzyme A synthetase or acyltransferase reactions. Stearic acid, which was incorporated into phospholipids to about the same extent as linoleic acid, did not inhibit arachidonic acid incorporation. Because stearic acid also had to be converted to the acyl coenzyme A derivative before esterification, competition at the level of fatty acid activation appears unlikely. On the other hand, there is some evidence that separate microsomal acyl coenzyme A synthetases activate longchain saturated and polyunsaturated fatty acids (25) , so that competition at this step might possibly occur between arachidonate and linoleate but not stearate. The present results, however, are much more consistent with a mechanism in which competition occurs at the acyltransferase step. Arachidonate should be incorporated primarily into position 2 of the glycerophospholipids (26) , and polyunsaturates are known to compete much more effectively than saturates for this 2-acyltransferase reaction (27) . Our findings that linoleic and eicosatrienoic acids, but not stearic acid, reduce arachidonate incorporation into the endothelial cell phospholipids, are in complete agreement with these previous observations.
Assuming that these results with umbilical vein cultures are representative of the physiologic situation, it appears that the endothelium requires a source of preformed arachidonic acid in order to maintain its intracellular arachidonate stores. This could be provided either as plasma free fatty acid or in the form of esterified fatty acid contained in the plasma lipoprotein. In spite of the observed competition, our results demonstrate that arachidonic acid incorporation into cellular phospholipids persists even in the face of a large excess of stearic or linoleic acids. The endothelium apparently has evolved so that it can continue to incorporate some arachidonic acid into phospholipids even though the extracellular arachidonic acid concentration is low relative to other fatty acids. Although eicosatrienoic acid effectively inhibited arachidonic acid incorporation into phospholipids, appreciable amounts of this fatty acid normally are not present in the plasma. Furthermore, the endothelial cultures are able to convert eicosatrienoic to arachidonic acid, providing some protection against arachidonic acid depletion should the eicosatrienoate level begin to build up. Another mechanism that probably contributes to the maintenance of the intracellular arachidonic acid content is its ready incorporation into triglycerides, even when the extracellular concentration is only ,mol/liter. With palmitic acid, much higher extracellular concentrations were required to obtain similar incorporations into endothelial cell triglycerides (28) . Taken together, these findings suggest that the human endothelial cell has developed efficient mechanisms for incorporating arachidonic acid into cellular lipids, perhaps to compensate for its inability to convert linoleate to arachidonate.
Whereas these mechanisms probably insure an adequate intracellular supply ofarachidonic acid under most conditions, the present results demonstrate that they may not be able to compensate adequately when a large excess of linoleic acid is available to the endothelium. Such a situation might arise when humans ingest a diet highly enriched in polyunsaturated fat. Linoleic acid is the predominant polyunsaturate when the diet is supplemented with either corn or safflower oil. When humans consume this type of diet, a large increase in linoleic acid occurs in all of the plasma lipoproteins within 7-14 d (29, 30) . Moreover, a single meal rich in these polyunsaturated fats can greatly increase the linoleic acid content of the chylomicron triglycerides and plasma free fatty acids within 4-6 h (31-34), and the plasma linoleic acid concentration can remain elevated for as long as 2 d (35). Within 6 h after feeding safflower oil, the plasma free fatty acid concentration increased from a base-line value of 0.32 to 0.55 gmol/ml (34) . Linoleic acid comprised 45% of the plasma free fatty acids after 6 h, or 0.25 umol/ml, as opposed to only 15%, or 0.048 ,umol/ml in the fasting state (34) . There is no increase in arachidonic acid under these conditions; in fact, the plasma arachidonic acid content decreased in several instances after polyunsaturated fats rich in linoleic acid were fed (34, 36) . The present findings suggest that the endothelium may not be able to compensate sufficiently for this type of circulating fatty acid compositional imbalance and that the amount of arachidonate present in cellular phospholipids may decrease under these conditions. Furthermore, previous studies with this cultured endothelial model system suggest that such modifications produced in intracellular fatty acid composition may be sufficient to decrease the capacity ofthe cells to form prostacyclin (6) . Because such a change could reduce the protective action of the endothelium against arterial vasoconstriction or thrombosis, it becomes important to determine whether a similar effect will occur in vivo in response to feeding large quantities of polyunsaturated fat.
